JP2004532642A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532642A5 JP2004532642A5 JP2003503770A JP2003503770A JP2004532642A5 JP 2004532642 A5 JP2004532642 A5 JP 2004532642A5 JP 2003503770 A JP2003503770 A JP 2003503770A JP 2003503770 A JP2003503770 A JP 2003503770A JP 2004532642 A5 JP2004532642 A5 JP 2004532642A5
- Authority
- JP
- Japan
- Prior art keywords
- culture
- medium
- during
- glucose
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 35
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 16
- 239000008103 glucose Substances 0.000 claims 16
- 239000002609 medium Substances 0.000 claims 15
- 239000006143 cell culture medium Substances 0.000 claims 12
- 239000000654 additive Substances 0.000 claims 5
- 230000000996 additive effect Effects 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- 238000012258 culturing Methods 0.000 claims 5
- 239000002054 inoculum Substances 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 3
- 210000004102 animal cell Anatomy 0.000 claims 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 3
- 238000010899 nucleation Methods 0.000 claims 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 1
- 101150013553 CD40 gene Proteins 0.000 claims 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims 1
- 235000021120 animal protein Nutrition 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- 230000000977 initiatory effect Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29801301P | 2001-06-13 | 2001-06-13 | |
| PCT/US2002/018687 WO2002101019A2 (en) | 2001-06-13 | 2002-06-11 | Methods of culturing animal cells and polypeptide production in animal cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004532642A JP2004532642A (ja) | 2004-10-28 |
| JP2004532642A5 true JP2004532642A5 (https=) | 2006-01-05 |
Family
ID=23148629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003503770A Pending JP2004532642A (ja) | 2001-06-13 | 2002-06-11 | 動物細胞の培養方法と動物細胞でのポリペプチド産生 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030087372A1 (https=) |
| EP (1) | EP1404813A4 (https=) |
| JP (1) | JP2004532642A (https=) |
| AU (1) | AU2002316230A1 (https=) |
| CA (1) | CA2447791A1 (https=) |
| WO (1) | WO2002101019A2 (https=) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060235209A9 (en) * | 1997-03-10 | 2006-10-19 | Jin-An Jiao | Use of anti-tissue factor antibodies for treating thromboses |
| US20030109680A1 (en) * | 2001-11-21 | 2003-06-12 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
| US5986065A (en) * | 1997-03-10 | 1999-11-16 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
| US7749498B2 (en) * | 1997-03-10 | 2010-07-06 | Genentech, Inc. | Antibodies for inhibiting blood coagulation and methods of use thereof |
| EP1360314B1 (en) | 2001-02-15 | 2009-01-14 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| CN100383238C (zh) * | 2003-05-09 | 2008-04-23 | 克鲁塞尔荷兰公司 | E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法 |
| ATE472597T2 (de) * | 2003-05-15 | 2010-07-15 | Wyeth Llc | Kontrollierte glukosezufuhr für tierzellkultur |
| AU2004255553B2 (en) * | 2003-06-19 | 2009-08-20 | Genentech, Inc. | Compositions and methods for treating coagulation related disorders |
| JP4740138B2 (ja) * | 2003-10-10 | 2011-08-03 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 真核生物細胞におけるポリペプチドの大規模生産方法及びそれに適した培養容器 |
| RU2451082C2 (ru) * | 2004-08-27 | 2012-05-20 | Вайет Рисёрч Айрлэнд Лимитед | Производство полипептидов |
| TWI364458B (en) * | 2004-08-27 | 2012-05-21 | Wyeth Res Ireland Ltd | Production of tnfr-lg |
| TWI384069B (zh) * | 2004-08-27 | 2013-02-01 | Pfizer Ireland Pharmaceuticals | 多胜肽之製法 |
| AU2012200353B2 (en) * | 2004-08-27 | 2014-06-19 | Pfizer Ireland Pharmaceuticals | PRODUCTION OF a-ABeta |
| TWI374935B (en) | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| EP3653699A1 (en) | 2006-01-04 | 2020-05-20 | Baxalta Incorporated | Oligopeptide-free cell culture media |
| US20070190057A1 (en) | 2006-01-23 | 2007-08-16 | Jian Wu | Methods for modulating mannose content of recombinant proteins |
| AR059065A1 (es) * | 2006-01-23 | 2008-03-12 | Amgen Inc | Metodos para modular el contenido de manosa de las proteinas recombinantes |
| TWI456062B (zh) | 2006-09-13 | 2014-10-11 | Abbvie Inc | 細胞培養改良 |
| CA2679941C (en) * | 2007-03-02 | 2016-09-20 | Wyeth | Use of copper and glutamate in cell culture for production of polypeptides |
| CA2682292A1 (en) * | 2007-03-30 | 2008-10-09 | Medimmune, Llc | Aqueous formulation comprising an anti-human interferon alpha antibody |
| TWI601823B (zh) | 2007-04-26 | 2017-10-11 | 中外製藥股份有限公司 | Cell culture methods using media containing high concentrations of amino acids |
| KR20190140090A (ko) | 2007-07-09 | 2019-12-18 | 제넨테크, 인크. | 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지 |
| WO2009023562A2 (en) | 2007-08-09 | 2009-02-19 | Wyeth | Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| EP2310523B1 (en) * | 2008-04-17 | 2015-06-10 | Wyeth LLC | Methods for enhanced production of bone morphogenetic proteins |
| WO2010016943A2 (en) * | 2008-08-08 | 2010-02-11 | Biogen Idec Ma Inc. | Nutrient monitoring and feedback control for increased bioproduct production |
| CN104059955A (zh) | 2009-08-11 | 2014-09-24 | 弗·哈夫曼-拉罗切有限公司 | 在无谷氨酰胺的细胞培养基中的蛋白质生产 |
| WO2011051231A1 (en) | 2009-10-26 | 2011-05-05 | F. Hoffmann-La Roche Ag | Method for the production of a glycosylated immunoglobulin |
| ES2642629T3 (es) | 2009-11-17 | 2017-11-17 | E. R. Squibb & Sons, L.L.C. | Métodos para la producción mejorada de proteínas |
| WO2011085095A2 (en) * | 2010-01-07 | 2011-07-14 | Dr. Reddy's Laboratories Ltd. | Enhanced protein expression |
| SG185037A1 (en) | 2010-04-26 | 2012-11-29 | Novartis Ag | Improved cell culture medium |
| US9428727B2 (en) | 2010-04-26 | 2016-08-30 | Novartis Ag | Cell culture medium |
| AU2011246502B2 (en) | 2010-04-26 | 2014-08-28 | Novartis Ag | Improved cell cultivation process |
| CA2810731A1 (en) * | 2010-09-17 | 2012-03-22 | Baxter International Inc. | Stabilization of immunoglobulins and other proteins through aqueous formulation with sodium chloride at weak acidic to neutral ph |
| EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| MY166973A (en) * | 2011-04-29 | 2018-07-27 | Biocon Res Limited | Methods for reducing accumulation of lactate during culturing and method for producing polypeptide |
| PL2702164T3 (pl) | 2011-04-29 | 2016-06-30 | Biocon Res Limited | Sposób obniżania heterogeniczności przeciwciał i sposób ich wytwarzania |
| DK2726600T3 (en) | 2011-07-01 | 2017-05-15 | Amgen Inc | Mammalian Cell Culture |
| WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| RU2496869C1 (ru) * | 2012-04-23 | 2013-10-27 | Государственное научное учреждение Прикаспийский зональный научно-исследовательский ветеринарный институт Российской академии сельскохозяйственных наук | Способ культивирования клеток человека и животных |
| US20130281355A1 (en) | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| SI2970875T2 (sl) | 2013-03-15 | 2026-03-31 | F. Hoffmann-La Roche Ag | Sestavki celičnih kultur z antioksidanti in postopki za proizvodnjo polipeptidov |
| CN105378480B (zh) | 2013-07-04 | 2018-06-12 | 豪夫迈·罗氏有限公司 | 检测血清样品中抗药物抗体的干扰抑制性免疫测定 |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| WO2015115849A1 (ko) * | 2014-01-29 | 2015-08-06 | 주식회사 엘지생명과학 | 배양배지의 최적화를 통한 재조합 단백질의 갈락토오스화를 조절하는 방법 |
| US10590455B2 (en) | 2014-02-25 | 2020-03-17 | Dr. Reddy's Laboratories Limited | Process for modifying galactosylation and G0F content of a glycoprotein composition by glutamine supplementation |
| MA40864A (fr) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères |
| KR20250025516A (ko) | 2014-12-22 | 2025-02-21 | 젠자임 코포레이션 | 포유류 세포의 배양 방법 |
| TW202440904A (zh) | 2015-08-04 | 2024-10-16 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法（二） |
| BR112020019559A2 (pt) | 2018-03-26 | 2021-01-12 | Amgen Inc. | Glicoformas afucosiladas totais de anticorpos produzidos em cultura de células |
| JP2020005511A (ja) * | 2018-07-03 | 2020-01-16 | 株式会社日立製作所 | 培養方法及び培養装置 |
| WO2020229584A1 (en) * | 2019-05-16 | 2020-11-19 | Formycon Ag | Method for reducing methionine oxidation in recombinant proteins |
| CN110257319A (zh) * | 2019-07-26 | 2019-09-20 | 苏州瑞徕生物科技有限公司 | 一种微载体上细胞维持培养的培养液及方法 |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| US11180540B2 (en) | 2019-12-06 | 2021-11-23 | Regeneron Pharmaceuticals, Inc. | Anti-VEGF protein compositions and methods for producing the same |
| JP2023525034A (ja) | 2020-05-08 | 2023-06-14 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｖｅｇｆトラップおよびミニトラップならびに眼障害およびがんの治療方法 |
| JP2023538881A (ja) * | 2020-08-14 | 2023-09-12 | ブリストル－マイヤーズ スクイブ カンパニー | タンパク質の製造方法 |
| KR20230170728A (ko) * | 2021-04-14 | 2023-12-19 | 젠자임 코포레이션 | 포유류 세포의 관류 배양 방법 |
| EP4330280A1 (en) * | 2021-04-27 | 2024-03-06 | Amgen Inc. | Modulating product quality of asymmetric multispecific antibodies through the use of temperature |
| CN115927160B (zh) * | 2022-12-28 | 2025-05-30 | 无锡药明生物技术股份有限公司 | 细胞培养基测试方法及其在生物制药中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US30985A (en) * | 1860-12-18 | Thomas l | ||
| US3926723A (en) * | 1974-08-08 | 1975-12-16 | Massachusetts Inst Technology | Method of controllably releasing glucose to a cell culture medium |
| US4560655A (en) * | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) * | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) * | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4724206A (en) * | 1984-02-13 | 1988-02-09 | Damon Biotech, Inc. | Protein production using hypertonic media |
| US5672502A (en) * | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
| US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| US6238891B1 (en) * | 1987-11-18 | 2001-05-29 | Cetus Oncology Corporation | Method of increasing product expression through solute stress |
| US5151359A (en) * | 1988-05-19 | 1992-09-29 | Mitsui Toatsu Chemicals Incorporated | Method for producing of human tissue type plasminogen activator |
| US5122469A (en) * | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US6180403B1 (en) * | 1999-10-28 | 2001-01-30 | Isis Pharmaceuticals Inc. | Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| US5736137A (en) * | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| US5856179A (en) * | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US5721121A (en) * | 1995-06-06 | 1998-02-24 | Genentech, Inc. | Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein |
| US5705364A (en) * | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| JP4306813B2 (ja) * | 1995-09-19 | 2009-08-05 | アスビオファーマ株式会社 | 動物細胞の新規培養方法 |
| US6087129A (en) * | 1996-01-19 | 2000-07-11 | Betagene, Inc. | Recombinant expression of proteins from secretory cell lines |
| WO1998041611A1 (en) * | 1997-03-20 | 1998-09-24 | Regents Of The University Of Minnesota | Process for the continuous culture of cells |
| US6237791B1 (en) * | 1997-04-09 | 2001-05-29 | Dtl Technology Limited Partnership | Wide mouth hot fill container |
| US6171586B1 (en) * | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| US6172213B1 (en) * | 1997-07-02 | 2001-01-09 | Genentech, Inc. | Anti-IgE antibodies and method of improving polypeptides |
| US5994511A (en) * | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
-
2002
- 2002-06-11 AU AU2002316230A patent/AU2002316230A1/en not_active Abandoned
- 2002-06-11 WO PCT/US2002/018687 patent/WO2002101019A2/en not_active Ceased
- 2002-06-11 EP EP02746513A patent/EP1404813A4/en not_active Withdrawn
- 2002-06-11 JP JP2003503770A patent/JP2004532642A/ja active Pending
- 2002-06-11 US US10/167,517 patent/US20030087372A1/en not_active Abandoned
- 2002-06-11 CA CA002447791A patent/CA2447791A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532642A5 (https=) | ||
| JP6603628B2 (ja) | 改良型細胞培養培地 | |
| JP6982578B2 (ja) | 細胞培養培地 | |
| KR101828624B1 (ko) | 개선된 세포 배양 방법 | |
| JP6001456B2 (ja) | 動物細胞の培養方法 | |
| RU2642285C1 (ru) | Способ получения целевого антитела с модулированным галактозилированием (варианты) и способ модулирования галактозилирования целевого антитела (варианты) путем оптимизации культуральной среды | |
| JP3934877B2 (ja) | 動物細胞培養用無血清培地 | |
| AU2014288811B2 (en) | Improved process for production of monoclonal antibodies | |
| RU2008113220A (ru) | Способ получения белков с использованием соединений, препятствующих старению | |
| BR122021007265B1 (pt) | Métodos para cultivar células de mamífero cho expressando uma proteína recombinante | |
| RU2009138226A (ru) | Способы производства белка с использованием соединений, препятствующих старению | |
| CN106536746A (zh) | 用于生产蛋白的细胞培养方法 | |
| JP2020115867A (ja) | かん流培地 | |
| US10526631B1 (en) | Method of reducing serine for asparagine misincorporation | |
| US11254964B1 (en) | Cell culture methods for increased cell viability | |
| CN119351502B (zh) | 抗体的制备方法 | |
| JPWO2020219582A5 (https=) | ||
| HK1238298A1 (en) | Cell culture process for producing a protein | |
| EA200500695A1 (ru) | Процедура получения клеточных линий в безбелковых средах и клеточные линии, полученные этим способом |